Inflammatory bowel disease (IBD) is a serious condition. It significantly increases the risk of colon cancer in patients that have any type of IBD. Although there are numerous conventional treatments, they come with significant side effects. But promising studies suggest that anti-inflammatory antioxidants such as alpha lipoic acid and curcumin from turmeric could help. (ii.10, 189-193)
There are 2 main types of IBD: (ii.189-191)
The exact cause of IBD is not yet known. However, experts believe it's related to an abnormal immune system response to microbes in the intestine. Researchers have identified certain factors known to be associated with increased susceptibility or risk of developing the disease. These include: (ii.189, 195-198)
Risk Factor | Crohn's Disease | Ulcerative Colitis |
---|---|---|
Arthritis | ♦ | |
Depression | ♦ | |
Diabetes | ♦ | |
Ethnicity | ♦ | ♦ |
Family History | ♦ | ♦ |
Irritable Bowel Syndrome (IBS) | ♦ | ♦ |
Medications | ♦ | ♦ |
Race | ♦ | |
Smoking | ♦ | |
Stress | ♦ |
The primary goal is to reduce inflammation. This often requires a multi-prong approach to relieve symptoms and put the disease in long-term remission. Conventional treatment for IBD includes: (ii.192)
As a last resort, surgery is sometimes recommended. (ii.192)
However, IBD medications often have side effects, including: (ii.192)
Alpha lipoic acid has antioxidant and anti-inflammatory properties that could help reduce IBD flares. Results from animal studies suggest that alpha lipoic acid could help treat colitis. It may even reverse inflammatory damage in the intestinal tract. (ii.197)
Some of the ways alpha lipoic works, according to these studies, include: (ii.197)
Alpha lipoic acid also supports how well mitochondria function in our cells. This may be important since some researchers suggest a link between mitochondrial dysfunction and IBD. Mitochondria are the organelles in cells that produce cell energy, but when they aren't working properly they produce large amounts of dangerous, inflammatory free radicals. (ii.198)
In a 6-week clinical study 10 patients with mild to moderate ulcerative colitis were given daily oral alpha lipoic acid supplements. Study participants were also given a therapeutic enema regimen. Alpha lipoic acid helped put the disease in remission in 90% of patients. (ii.10)
In preclinical studies, both cyclosporine and alpha lipoic acid appear to be beneficial against colitis. However, researchers suggest that using alpha lipoic acid while taking cyclosporine could increase colon damage. In an animal study, treating with both substances at the same time increased free radicals, inflammation, and colon ulcers. (ii.199)